Food Safety Crackdown: Taiwan’s tainted cooking oil recall widened to 401 products after Central Union Oil Corp was linked to soy-based cooking oil with excessive benzopyrene, prompting store-shelf removals and renewed public trust concerns. Legal Pressure: Prosecutors sought detention of Central Union’s general manager over alleged violations of the Food Safety Act, while courts granted NT$20 million bail and prosecutors immediately appealed. Cancer Drug Update: GSK and Hansoh reported Phase 3 success in China for the B7-H3 antibody-drug conjugate ris-rez (risvutatug rezetecan), meeting its overall survival goal in advanced or relapsed small-cell lung cancer and supporting regulatory filing plans. Obesity & Reflux Screening: A study found high-resolution impedance manometry can detect physiologic GERD in many obese patients even when symptoms are mild, suggesting better reflux assessment before bariatric surgery. Taiwan Finance Watch: Taiwan’s AI-driven stock market boom is widening earnings gaps across financial subsectors, with securities firms benefiting most while leasing firms face pressure. Regional Pharma Expansion: Bristol Myers Squibb named Singapore a Pan Asia Cluster hub covering Taiwan and other regional markets to expand talent and improve patient access. Policy Debate: Taiwan’s political parties are pushing ahead with referendums, including a proposed euthanasia referendum, as the island remains a super-aged society.